β2-M has been previously shown to activate several pathways in cancer cells such as protein kinase A 28, vascular endothelial growth factor 29, androgen receptor 7, fatty acid synthase 7 and lipid raft signaling pathways 3. This evidence concerns the gene B2M and cancer.